Annual Shareholders Equity
$236.24 M
-$99.92 M-29.72%
31 December 2023
Summary:
Centessa Pharmaceuticals annual stockholders equity is currently $236.24 million, with the most recent change of -$99.92 million (-29.72%) on 31 December 2023. During the last 3 years, it has risen by +$258.67 million (+1153.58%). CNTA annual shareholders equity is now -69.82% below its all-time high of $782.66 million, reached on 01 June 2020.CNTA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$499.14 M
+$212.17 M+73.94%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly stockholders equity is currently $499.14 million, with the most recent change of +$212.17 million (+73.94%) on 30 September 2024. Over the past year, it has increased by +$239.75 million (+92.43%). CNTA quarterly shareholders equity is now -14.77% below its all-time high of $585.64 million, reached on 30 June 2021.CNTA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.7% | +92.4% |
| 3 y3 years | +1153.6% | -9.1% |
| 5 y5 years | -55.0% | - |
CNTA Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -51.9% | +1153.6% | -9.1% | +132.0% |
| 5 y | 5 years | -69.8% | +1153.6% | -14.8% | +132.0% |
| alltime | all time | -69.8% | +1153.6% | -14.8% | +132.0% |
Centessa Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $499.14 M(+73.9%) |
| June 2024 | - | $286.96 M(+33.4%) |
| Mar 2024 | - | $215.16 M(-8.9%) |
| Dec 2023 | $236.24 M(-29.7%) | $236.24 M(-8.9%) |
| Sept 2023 | - | $259.39 M(-6.2%) |
| June 2023 | - | $276.61 M(-5.7%) |
| Mar 2023 | - | $293.26 M(-12.8%) |
| Dec 2022 | $336.17 M(-31.6%) | $336.17 M(-9.9%) |
| Sept 2022 | - | $372.92 M(-11.2%) |
| June 2022 | - | $420.04 M(-12.5%) |
| Mar 2022 | - | $480.15 M(-2.3%) |
| Dec 2021 | $491.55 M | $491.55 M(-10.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $549.13 M(-6.2%) |
| June 2021 | - | $585.64 M(+110.2%) |
| Mar 2021 | - | $278.63 M |
| Dec 2020 | -$22.42 M(-102.9%) | - |
| June 2020 | $782.66 M(+49.1%) | - |
| June 2019 | $524.94 M(+10.4%) | - |
| June 2018 | $475.64 M(+21.6%) | - |
| June 2017 | $391.11 M(+4.4%) | - |
| June 2016 | $374.58 M(+37.0%) | - |
| June 2015 | $273.44 M(<-9900.0%) | - |
| May 2015 | -$44.10 K(-712.5%) | - |
| May 2014 | $7200.00 | - |
FAQ
- What is Centessa Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual shareholders equity year-on-year change?
- What is Centessa Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Centessa Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of CNTA is $236.24 M
What is the all time high annual shareholders equity for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual stockholders equity is $782.66 M
What is Centessa Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, CNTA annual stockholders equity has changed by -$99.92 M (-29.72%)
What is Centessa Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of CNTA is $499.14 M
What is the all time high quarterly shareholders equity for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly stockholders equity is $585.64 M
What is Centessa Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, CNTA quarterly stockholders equity has changed by +$239.75 M (+92.43%)